Sarepta therapeutics announces call for applications for the 8th annual route 79, the duchenne scholarship program

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today announced the official opening of route 79, the duchenne scholarship program for the 2025-2026 academic year. academic scholarships of up to $5,000 will be awarded to as many as 20 individuals living with duchenne muscular dystrophy and 5 siblings of individuals living with duchenne. “in the past decade, there have been significant advancements in the tr.
SRPT Ratings Summary
SRPT Quant Ranking